Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alissa S Marr

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Thoracic Disease|September 14, 2016
Resected small cell lung cancer-time for more?Alissa S Marr, Chi Zhang, Apar Kishor Ganti
Journal of the National Comprehensive Cancer Network : JNCCN|July 5, 2014
Management of patients with lung cancer and poor performance statusAjeet Gajra, Alissa S Marr, Apar Kishor Ganti
Oncology (Williston Park, N.Y.)|June 20, 2024
A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A MutationJonathan Q Trinh, Shristi Upadhyay Banskota, Alissa S Marr
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2019
Association Between Hospital Volume, Therapy Types, and Overall Survival in Stage III and IV Cutaneous Malignant MelanomaSri Harsha Tella, Anuhya Kommalapati, Apar Kishor Ganti, et al.
American Journal of Clinical Oncology|January 11, 2011
Predictive ability of Charlson comorbidity index on outcomes from lung cancerApar Kishor Ganti, Emily Siedlik, Alissa S Marr, et al.
Oncology (Williston Park, N.Y.)|December 19, 2024
Clinical Trial Eligibility and Outcomes in Patients With Metastatic NSCLC Treated Outside of Clinical TrialsClayton K Oakley, Amulya Yellala, Sunil Tulpule, et al.
Anticancer Research|February 2, 2024
Durvalumab Outcomes in Stage III Non-small Cell Lung Cancer: A Single-institution StudyJonathan Q Trinh, Ying Xiong, Lynette M Smith, et al.
Clinical Lung Cancer|January 5, 2016
Early Stage Non-Small-Cell Lung Cancer in Octogenarian and Older Patients: A SEER Database AnalysisApar Kishor Ganti, Valerie Shostrom, Mohamed Alorabi, et al.
Journal of Geriatric Oncology|August 6, 2016
Weekly vinorelbine and paclitaxel in older patients with advanced non-small cell lung cancer: A phase II Fred and Pamela Buffet Cancer Center Clinical Trials Network studyMary M Huerter, Jane L Meza, M Sitki Copur, et al.
Cancer Treatment and Research Communications|November 2, 2019
A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network studyVinicius Ernani, Rahat Jahan, Lynette M Smith, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Thoracic Disease|September 14, 2016
Resected small cell lung cancer-time for more?Alissa S Marr, Chi Zhang, Apar Kishor Ganti
Journal of the National Comprehensive Cancer Network : JNCCN|July 5, 2014
Management of patients with lung cancer and poor performance statusAjeet Gajra, Alissa S Marr, Apar Kishor Ganti
Oncology (Williston Park, N.Y.)|June 20, 2024
A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A MutationJonathan Q Trinh, Shristi Upadhyay Banskota, Alissa S Marr
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2019
Association Between Hospital Volume, Therapy Types, and Overall Survival in Stage III and IV Cutaneous Malignant MelanomaSri Harsha Tella, Anuhya Kommalapati, Apar Kishor Ganti, et al.
American Journal of Clinical Oncology|January 11, 2011
Predictive ability of Charlson comorbidity index on outcomes from lung cancerApar Kishor Ganti, Emily Siedlik, Alissa S Marr, et al.
Oncology (Williston Park, N.Y.)|December 19, 2024
Clinical Trial Eligibility and Outcomes in Patients With Metastatic NSCLC Treated Outside of Clinical TrialsClayton K Oakley, Amulya Yellala, Sunil Tulpule, et al.
Anticancer Research|February 2, 2024
Durvalumab Outcomes in Stage III Non-small Cell Lung Cancer: A Single-institution StudyJonathan Q Trinh, Ying Xiong, Lynette M Smith, et al.
Clinical Lung Cancer|January 5, 2016
Early Stage Non-Small-Cell Lung Cancer in Octogenarian and Older Patients: A SEER Database AnalysisApar Kishor Ganti, Valerie Shostrom, Mohamed Alorabi, et al.
Journal of Geriatric Oncology|August 6, 2016
Weekly vinorelbine and paclitaxel in older patients with advanced non-small cell lung cancer: A phase II Fred and Pamela Buffet Cancer Center Clinical Trials Network studyMary M Huerter, Jane L Meza, M Sitki Copur, et al.
Cancer Treatment and Research Communications|November 2, 2019
A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network studyVinicius Ernani, Rahat Jahan, Lynette M Smith, et al.
Pageof 2